Literature DB >> 11339762

On the applicability of the AAPM TG-60/TG-43 dose calculation formalism to intravascular line sources: proposal for an adapted formalism.

D R Schaart1, M C Clarijs, A J Bos.   

Abstract

Despite the widely recognized usefulness of the AAPM TG-43 brachytherapy dose calculation formalism, a straightforward application of this approach to describe the dose distribution about intravascular line sources as proposed by TG-60 may be difficult or even impossible, especially when these line sources emit low-energy photons or beta particles. The causes of these limitations are investigated and illustrated by means of some numerical examples. In order to solve the observed limitations an adapted formalism is proposed, intended specifically for the description of the dose rate distribution about line sources but conceptually similar to the TG-43/TG-60 formalism. Several examples are presented to illustrate the usefulness of the proposed line source dose calculation formalism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11339762     DOI: 10.1118/1.1357458

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  Variation in PPP3CC Genotype Is Associated with Long-Term Recovery after Severe Brain Injury.

Authors:  Nicole D Osier; James W Bales; Bunny Pugh; Samuel Shin; Julie Wyrobek; Ava M Puccio; David O Okonkwo; Dianxu Ren; Sheila Alexander; Yvette P Conley; C Edward Dixon
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

2.  Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.

Authors:  Ali S Meigooni; Shahid B Awan; Venkata Rachabatthula; Rafiq A Koona
Journal:  J Appl Clin Med Phys       Date:  2005-08-12       Impact factor: 2.102

3.  Cylindrical coordinate based TG-43U1 parameters for dose calculation around elongated brachytherapy sources.

Authors:  Shahid B Awan; Sharifeh A Dini; Manzoor Hussain; David Soleimani-Meigooni; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2008-04-16       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.